Key result
Continuous intravenous insulin infusion shows no clear benefit for early outcomes after off-pump CABG.
Answers are grounded in this paper and cite their sources.
May not yet alter glycemic management in diabetic off-pump CABG; leaves open need for randomized evidence on insulin infusion.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hoque et al. (2026) studied this question. Continuous intravenous insulin infusion was evaluated for its effect on early outcomes after off-pump coronary artery bypass grafting in diabetic patients.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: